Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT04742933
Eligibility Criteria:
Inclusion Criteria:
* History of PCI for stable CAD
* Referred for a diagnostic ICA.
* Age above 30 years.
Exclusion Criteria:
* History of severe COPD or chronic asthma
* Pregnancy
* Renal failure (eGFR \<30 mL/min)
* Use of sildenafil (Viagra) or dipyramidol (Persantin) that cannot be terminated
* Contra-indications for β-blockers
* Allergic reaction to iodized contrast
* Concurrent or prior (within last 30 days) participation in other research studies using investigational drugs
* Claustrophobia
* Significant co-morbidities
* Atrial fibrillation, second or third degree atrioventricular block
* Tachycardia
* Acute myocardial infarction
* History of CABG
* Heart failure
* Cardiomyopathies
* Previous radiation exposure in the diagnostic work-up
* Unable to give informed consent
* Indispensable follow-up with (serial) CT scans for non-cardiac related condition
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT04742933
Study Brief:
Protocol Section:
NCT04742933